TSS
XFOR icon

Two Sigma Securities’s X4 Pharmaceuticals XFOR Stock Holding History

Two Sigma Securities’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-403
Closed -$8.09K – 3361
2024
Q3 		$8.09K Buy
+403
New +$8.41K ﹤0.01% 2630
2024
Q2 		– Sell
-984
Closed -$41K – 3750
2024
Q1 		$41K Buy
+984
New +$27.4K ﹤0.01% 2596
2023
Q4 		– Sell
-1,078
Closed -$35.2K – 3677
2023
Q3 		$35.2K Buy
+1,078
New +$47K ﹤0.01% 2509

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Securities's XFOR Position: Q4 2024 in Review

Two Sigma Securities sold out of X4 Pharmaceuticals (XFOR) in Q4 2024, closing a stake of 403 shares — an estimated $8.09K sold.

Two Sigma Securities first reported a position in XFOR in Q3 2023 and held it in 3 quarters. The position peaked at $41K in Q1 2024. 89 funds tracked by Wall St. Rank hold XFOR as of Q4 2024.

  • Two Sigma Securities reported no remaining X4 Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 403 X4 Pharmaceuticals shares in Q4 2024, an estimated $8.09K.
  • Two Sigma Securities first reported a position in X4 Pharmaceuticals in Q3 2023 and held it in 3 quarters.
  • Two Sigma Securities's X4 Pharmaceuticals position peaked at $41K in Q1 2024.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.